Scientific Manager within Obesity and Nutritional Sciences
Would you like to be a part of an ambitious and dedicated team and contribute to our goal of improving people’shealth and fight social inequity in health through investments in obesity and nutritional research and science? Do you find purpose in creating long-term societal impact by developing and supporting excellent research projects to expand our knowledge, and to translate knowledge into practice?
The Novo Nordisk Foundation’s (NNF) Obesity and Nutritional Sciences programme area is looking for a Scientific Manager with experience in overweight, obesity and nutritional disorders and more specific in e.g., how to prevent and manage overweight and obesity, precision management of obesity, weight loss as a tool to prevent other comorbidities, nutritional therapy as a novel innovative tool to manage both physical and mental conditions and diseases.
The Obesity amp; Nutritional Sciences team, headed by SVP, Professor Arne Astrup, currently consists of seven highly qualified and passionate colleagues with diverse backgrounds. Our team leads the development of strategic initiatives and manage grants that support obesity and nutritional research and implementation both in Denmark and globally, mainly Denmark and Global North.
Joining our team means being part of a dynamic and diverse community where your expertise and individuality contribute to the collective pursuit of societal impact and scientific excellence. In the team we act as close sparring partners, and we value creativity, integrity, and good collegial relationships. You will also have the opportunity to develop your project management skills as project centricity is core in the Foundation. We work in close collaboration with other NNF teams and with external stakeholders from society, academia, and industry.
As Scientific Manager you will, together with colleagues in-house and key external partners, identify, evaluate, and co-develop excellent research projects to be granted by the Foundation. The focus areas are the understanding, prevention, and management of overweight and obesity and the link to obesity related diseases (mainly Global North); nutritional aspects of over- and malnutrition; and nutrition and weight control as a therapeutic tool to fight diseases and adverse health and mental conditions. You will build and manage a portfolio of projects, where you will support the grant holders during the entire lifetime of the projects to ensure the highest quality output and impact. The workplace is at the Novo Nordisk Foundation’s offices in Hellerup, Denmark. Travel and occasional meetings outside normal work hours must be expected.
Your tasks will initially include:
Professional and Personal Qualifications
The ideal candidate has a keeninterest in and research experience with obesity and nutritional sciences. Furthermore we expect that you have:
As a person, you are:
Working at the Novo Nordisk Foundation
We offer a committed and professional workplace in which we emphasize ensuring that our colleagues thrive, are challenged and have opportunities to develop their potential. A career at the Novo Nordisk Foundation gives you the opportunity to work:
Application and further information
For more information, please contact Senior Vice President Arne Astrup, . We encourage you to upload your application as soon as possible and no than later 27th February 2024. We are looking for a colleague who preferentially could start 1 May 2024.
To apply, please upload your CV, short cover letter, and PhD diploma by clicking on the Apply button.
About the Novo Nordisk Foundation
The Novo Nordisk Foundation dates back to 1922, and is an independent Danish foundation with corporate interests. Our vision is to contribute significantly to research and development that improves the lives of people and the sustainability of society.
In the period 2018-2022, the Novo Nordisk Foundation has awarded DKK 30.6 billion through more than 3,150 grants. Of these, 44% (DKK 13.4 billion) were awarded for physiological, endocrinological, metabolic and other medical research, 5% (DKK 1.5 billion) have been awarded for research hospital activities within diabetes and 51% (DKK 15.6 billion), were awarded for other scientific, humanitarian and social purposes, respectively. The Foundation gets its income from ownership in the Novo Group companies and more than 160 other life science companies.
In the coming years, the Foundation will further broaden its scope and increase its grants for scientific, humanitarian and social purposes. As a consequence, we are a growing organization, which means new job openings and exciting opportunities for employees to be a part of forming the future of the Foundation.
Read more about the Novo Nordisk Foundation’s history, strategy and ownership structure here: Frontpage - Novo Nordisk Fonden.